Autoimmune Disease Testing Market is Expected to Grow at High CAGR during the forecast period 2024

The Autoimmune Disease Testing Market has exhibited remarkable growth, reaching a valuation of USD 11.24 billion in 2023. Projections suggest an even more impressive trajectory, with expectations pointing towards a valuation of approximately USD 24.14 billion by 2031. This anticipated expansion reflects a notable compound annual growth rate (CAGR) of 10.27% over the forecast period spanning from 2024 to 2031. Such growth underscores the increasing prevalence of autoimmune diseases worldwide and the growing demand for accurate diagnostic testing methods. As awareness about autoimmune conditions continues to rise and the need for early detection and effective management becomes paramount, the market for autoimmune disease testing is poised for significant development, driving innovation in diagnostic technologies and improving patient outcomes.